{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:28:03Z","timestamp":1777613283750,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T00:00:00Z","timestamp":1431561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1038\/ijo.2015.86","type":"journal-article","created":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T07:41:55Z","timestamp":1431589315000},"page":"1359-1364","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["The effect of sibutramine prescribing in routine clinical practice on cardiovascular outcomes: a cohort study in the United Kingdom"],"prefix":"10.1038","volume":"39","author":[{"given":"J F","family":"Hayes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Bhaskaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Batterham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Smeeth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,14]]},"reference":[{"key":"BFijo201586_CR1","unstructured":"National Institute for Health and Care Excellence Clinical Guideline 43: Obesity: the Prevention, Identification, Assessment and Management of Overweight and Obesity in Adults and Children. NICE: : London, UK, 2006."},{"key":"BFijo201586_CR2","doi-asserted-by":"publisher","first-page":"c824","DOI":"10.1136\/bmj.c824","volume":"340","author":"G Williams","year":"2010","unstructured":"Williams G . Withdrawal of sibutramine in Europe. BMJ 2010; 340: c824.","journal-title":"BMJ"},{"key":"BFijo201586_CR3","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJMoa1003114","volume":"363","author":"WP James","year":"2010","unstructured":"James WP, Caterson ID, Coutinho W, Finer N, Van Gaal LF, Maggioni AP et al. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med 2010; 363: 905\u2013917.","journal-title":"N Engl J Med"},{"key":"BFijo201586_CR4","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2165\/11592040-000000000-00000","volume":"34","author":"BM Cheung","year":"2011","unstructured":"Cheung BM . Drug treatment for obesity in the post-sibutramine era. Drug Saf 2011; 34: 641\u2013650.","journal-title":"Drug Saf"},{"key":"BFijo201586_CR5","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/j.1463-1326.2011.01554.x","volume":"14","author":"ID Caterson","year":"2012","unstructured":"Caterson ID, Finer N, Coutinho W, Van Gaal LF, Maggioni AP, Torp-Pedersen C et al. Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial. Diabetes Obes Metab 2012; 14: 523\u2013530.","journal-title":"Diabetes Obes Metab"},{"key":"BFijo201586_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000316508","volume":"3","author":"S Czernichow","year":"2010","unstructured":"Czernichow S, Batty GD . Withdrawal of sibutramine for weight loss: where does this leave clinicians? Obesity Facts 2010; 3: 155\u2013156.","journal-title":"Obesity Facts"},{"key":"BFijo201586_CR7","doi-asserted-by":"publisher","first-page":"c477","DOI":"10.1136\/bmj.c477","volume":"340","author":"A Sayburn","year":"2010","unstructured":"Sayburn A . Withdrawal of sibutramine leaves European doctors with just one obesity drug. BMJ 2010; 340: c477.","journal-title":"BMJ"},{"key":"BFijo201586_CR8","doi-asserted-by":"publisher","first-page":"615","DOI":"10.2165\/11538810-000000000-00000","volume":"33","author":"AJ Scheen","year":"2010","unstructured":"Scheen AJ . Controversy about the cardiovascular safety of sibutramine. Drug Saf 2010; 33: 615\u2013618.","journal-title":"Drug Saf"},{"key":"BFijo201586_CR9","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1111\/bcp.12578","volume":"79","author":"IJBK Douglas","year":"2015","unstructured":"Douglas IJ BK, Batterham R, Smeeth L . The effectiveness of pharmaceutical interventions for obesity: weight loss with orlistat and sibutramine in a United Kingdom population-based cohort. Br J Clin Pharmacol 2015; 79: 1020\u20131027.","journal-title":"Br J Clin Pharmacol"},{"key":"BFijo201586_CR10","unstructured":"Clinical Practice Research Datalink. \n                    http:\/\/www.cprd.com\n                    \n                  ."},{"key":"BFijo201586_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1177\/2042098611435911","volume":"3","author":"T Williams","year":"2012","unstructured":"Williams T, Van Staa T, Puri S, Eaton S . Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource. Ther Adv Drug Saf 2012; 3: 89\u201399.","journal-title":"Ther Adv Drug Saf"},{"key":"BFijo201586_CR12","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/qjmed\/91.6.445","volume":"91","author":"DH Lawson","year":"1998","unstructured":"Lawson DH, Sherman V, Hollowell J . The General Practice Research Database. Scientific and Ethical Advisory Group. QJM 1998; 91: 445\u2013452.","journal-title":"QJM"},{"key":"BFijo201586_CR13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1046\/j.1365-2125.1998.00701.x","volume":"45","author":"LA Garc\u00eda Rodr\u00edguez","year":"1998","unstructured":"Garc\u00eda Rodr\u00edguez LA, P\u00e9rez Gutthann S . Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol 1998; 45: 419\u2013425.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"BFijo201586_CR14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.14236\/jhi.v19i3.811","volume":"19","author":"Tim Benson","year":"2011","unstructured":"Benson T . The history of the Read codes: the inaugural James Read Memorial Lecture 2011. Inform Prim Care 19: 173\u2013182.","journal-title":"Journal of Innovation in Health Informatics"},{"key":"BFijo201586_CR15","unstructured":"The Office for National Statistics. Key Health Statistics from General Practice 1998. The Office for National Statstics: : London, UK, 2000."},{"key":"BFijo201586_CR16","unstructured":"London School of Hygiene and Tropical Medicine. \n                    http:\/\/www.lshtm.ac.uk\/study\/applicants\/shortcourses\/practical_pharmacoepidemiology__gprd_background.pdf\n                    \n                  ."},{"key":"BFijo201586_CR17","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2165\/11584800-000000000-00000","volume":"10","author":"AJ Scheen","year":"2010","unstructured":"Scheen AJ . Cardiovascular risk-benefit profile of sibutramine. Am J Cardiovasc Drugs 2010; 10: 321\u2013334.","journal-title":"Am J Cardiovasc Drugs"},{"key":"BFijo201586_CR18","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1002\/sim.3944","volume":"29","author":"IR White","year":"2010","unstructured":"White IR, Carlin JB . Bias and efficiency of multiple imputation compared with complete\u2010case analysis for missing covariate values. Stat Med 2010; 29: 2920\u20132931.","journal-title":"Stat Med"},{"key":"BFijo201586_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","volume":"70","author":"PR Rosenbaum","year":"1983","unstructured":"Rosenbaum PR, Rubin DB . The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70: 41\u201355.","journal-title":"Biometrika"},{"key":"BFijo201586_CR20","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1136\/bmj.319.7223.1492","volume":"319","author":"DG Altman","year":"1999","unstructured":"Altman DG, Andersen PK . Calculating the number needed to treat for trials where the outcome is time to an event. BMJ 1999; 319: 1492\u20131495.","journal-title":"BMJ"},{"key":"BFijo201586_CR21","unstructured":"StataCorp. Stata Statistical Software. StataCorp LP: College Station, TX, USA, 2009."},{"key":"BFijo201586_CR22","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1592\/phco.23.5.686.32205","volume":"23","author":"SS Jick","year":"2003","unstructured":"Jick SS, Kaye JA, Vasilakis\u2010Scaramozza C, Rodr\u00edguez LAG, Ruig\u00f3mez A, Meier CR et al. Validity of the general practice research database. Pharmacotherapy 2003; 23: 686\u2013689.","journal-title":"Pharmacotherapy"},{"key":"BFijo201586_CR23","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/sj.ijo.0803631","volume":"31","author":"R Padwal","year":"2007","unstructured":"Padwal R, Kezouh A, Levine M, Etminan M . Long-term persistence with orlistat and sibutramine in a population-based cohort. Int J Obes 2007; 31: 1567\u20131570.","journal-title":"Int J Obes"},{"key":"BFijo201586_CR24","doi-asserted-by":"crossref","unstructured":"Herrett E, Shah AD, Boggon R, Denaxas S, Smeeth L, van Staa T et al. Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study. BMJ 2013; 346.","DOI":"10.1136\/bmj.f2350"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ijo201586.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ijo201586","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ijo201586.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:30:19Z","timestamp":1684431019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ijo201586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,14]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["BFijo201586"],"URL":"https:\/\/doi.org\/10.1038\/ijo.2015.86","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,14]]},"assertion":[{"value":"18 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}